載入...
A rare case of sorafenib-induced severe hyponatremia
BACKGROUND: Sorafenib is an anti-angiogenic tyrosine kinase inhibitor used to treat patients with renal cell cancer and advanced hepatocellular cancer. Common adverse effects of sorafenib are rash, diarrhea, nausea, and abnormal liver function test and hand-foot syndrome. CASE PRESENTATION: Here, we...
Na minha lista:
| 發表在: | SAGE Open Med Case Rep |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488774/ https://ncbi.nlm.nih.gov/pubmed/31065359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X19846048 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|